Home/Filings/4/0001225208-12-016840
4//SEC Filing

Edwards Lifesciences Corp 4

Accession 0001225208-12-016840

$EWCIK 0001099800operating

Filed

Jul 29, 8:00 PM ET

Accepted

Jul 30, 5:46 PM ET

Size

15.3 KB

Accession

0001225208-12-016840

Insider Transaction Report

Form 4
Period: 2012-07-27
REINDL ROBERT C
CVP, H.R. and Communications
Transactions
  • Sale

    Common Stock

    2012-07-27$102.62/sh3,464$355,47651,736 total
  • Sale

    Common Stock

    2012-07-27$105.26/sh40,301$4,242,0831,124 total
  • Sale

    Common Stock

    2012-07-27$105.80/sh300$31,74058,288 total
  • Sale

    Common Stock

    2012-07-27$103.98/sh10,311$1,072,13841,425 total
  • Exercise/Conversion

    Common Stock

    2012-07-27$21.95/sh+54,000$1,185,57058,588 total
  • Exercise/Conversion

    Employee Stock Option (Right to Acquire)

    2012-07-2754,0000 total
    Exercise: $21.95From: 2007-05-11Exp: 2013-05-10Common Stock (54,000 underlying)
  • Sale

    Common Stock

    2012-07-27$103.06/sh3,088$318,24955,200 total
Footnotes (4)
  • [F1]This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person.
  • [F2]This transaction was executed in multiple trades at prices ranging from $102.62 to $103.53. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F3]This transaction was executed in multiple trades at prices ranging from $103.64 to $104.39. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F4]This transaction was executed in multiple trades at prices ranging from $104.77 to $105.74. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Documents

1 file

Issuer

Edwards Lifesciences Corp

CIK 0001099800

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001099800

Filing Metadata

Form type
4
Filed
Jul 29, 8:00 PM ET
Accepted
Jul 30, 5:46 PM ET
Size
15.3 KB